logo-loader
viewSavannah Resources PLC

Proactive news snapshot: Savannah Resources, ClearStar, IronRidge Resources...

A glance at some of the day's highlights from the Proactive Investors newswire

Savannah Resources PLC -

Savannah Resources PLC (LON:SAV) is to be awarded mining licences over the Mahab 4 and Maqail South high-grade copper deposits near the Port of Sohar in Oman.

Screening specialist ClearStar Inc (LON:CLSU) said its Medical Information Services (MIS) business has passed a significant milestone by posting monthly sales in excess of US$1mln for the first time.

IronRidge Resources Limited (LON:IRR) has signed a deal with Canadian listed explorer GeoDrill Limited (TSX:GEO) for a ‘drilling for equity’ program across its gold and lithium portfolio in Africa.

Touchstone Exploration Inc (LON:TXP) told investors that drilling operations have kicked off in the Ortoire block, in Trinidad.

Goldplat plc (LON:GDP) steadied in the second half of year just ended after cost-cutting and the mothballing of the Kilimapesa gold mine.

Block Energy PLC (LON:BLOE) has begun preparations to drill a second well at its promising West Rustavi field in Georgia.

Genel Energy PLC (LON:GENL) has resumed a US$10mln share buyback as part of an effort to boost its share price value.

Diversified Gas & Oil PLC (LON:DGOC) chief executive has told investors that the strategy to build scale within Appalachia continues to prove successful.

Motor finance and property bridging firm S & U PLC (LON:SUS) said it continues to trade well and in line with expectations despite a tough car market and a subdued housing market.

Arix Bioscience PLC’s (LON:ARIX) portfolio company Autolus has reported strong progress in the second quarter with encouraging data from a clinical trial of cancer drug AUTO1.

Vast Resources PLC (LON:VAST) has raised £655,000 through a placing of ordinary shares and plans to use the proceeds to fund its "strategic operational requirements" in Zimbabwe. The company said it continues to progress its financing discussions and maintains its production targets by the end of 2019.    

Sierra Oncology (NASDAQ:SRRA), which is developing a novel checkpoint kinase 1 inhibitor originally discovered by Sareum Holdings PLC (LON:SAR), said it is continuing to seek non-dilutive development support or funding for its lead development candidates.

Quick facts: Savannah Resources PLC

Price: 2.225 GBX

AIM:SAV
Market: AIM
Market Cap: £28.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Savannah Resources PLC named herein, including the promotion by the Company of Savannah Resources PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Savannah Resources’ Grandao lithium deposit ‘continues to grow’

David Archer, chief executive of Savannah Resources Plc (LON:SAV), tells Proactive Investors they're seeing continued encouraging results from their ongoing reverse circulation and diamond drill programme at the Mina do Barroso project in Portugal. He says they've identified 'significant...

on 26/7/18

2 min read